Search
for
Sort by
Research 301–330 of 582
- Topical JAK Inhibitors for the Treatment of Alopecia Areata and Vitiligo
- 546 Gene expression signatures and ALADIN score correlates with response of alopecia areata patients to treatment with JAK inhibitors
- SnapshotDx Quiz: March 2016
- Hair today, gone tomorrow
- Topical Drugs Regrow Hair In Mice
- Janus kinase (JAK)
- Down‐regulation of Shh in the hair follicles of mice during chemotherapy‐induced hair loss is mediated by the JAK / STAT1 signaling pathway
- Alopecia areata in children: an overview of clinical features and recent treatment options
- Experience with oral tofacitinib in 8 adolescent patients with alopecia universalis
- Tofacitinib Citrate for the Treatment of Nail Dystrophy Associated With Alopecia Universalis
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- Novedades terapéuticas en tricología
- New Treatments for Hair Loss
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Alopecia Areata: a Comprehensive Review of Pathogenesis and Management
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- JAK inhibitors and alopecia areata
- Establishment of an in vitro organoid model of dermal papilla of human hair follicle
- Tofacitinib therapy for children with severe alopecia areata
- Treatment of severe alopecia areata with baricitinib
- Systematic review and quality analysis of studies on the efficacy of topical diphenylcyclopropenone treatment for alopecia areata
- TREMendous Macrophages Inhibit Hair Growth
- 455 Molecular correlation with clinical outcomes in an open label clinical trial of oral tofacitinib in patients with alopecia areata
- Evidence for the off-label use of tofacitinib in alopecia areata
- Hair follicle stem cells and the collapse of self-tolerance in alopecia: the interplay of barrier function, the microbiome, and immunity
- Highlights
- Alopecia areata
- Tofacitinib for the treatment of severe alopecia areata and variants: A study of 90 patients
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis